October 3, 2023 — The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. 

October 3, 2023 — Medical device company GT Medical Technologies, Inc. announced interim findings of a multi-institutional study that demonstrates high local control for the treatment of recurrent brain metastases in patients. The findings add to the growing evidence of the efficacy and safety of its FDA-approved GammaTile Therapy, and were presented during an Oct.

October 3, 2023 — Using previously taken diagnostic computed tomography (CT) scans in place of CT simulation scans to plan simple palliative radiation treatments can substantially reduce the time some

October 2, 2023 — Digital radiography company Swissray has announced a strategic partnership with Koning Corporation, provider of advanced breast imaging solutions, whereby Swissray becomes the authorized distributor of the Koning Vera Breast CT for the Florida and Arizona regions.

October 2, 2023 — A novel liquid biopsy test may help determine which patients with non-small cell lung cancer that has spread beyond the lungs are most likely to benefit from targeted, high-dose radiation, rather than drug-based therapy, a new study suggests.

October 2, 2023 — A type of head and neck cancer predominantly diagnosed in people who reside in low- and middle-income countries may be treated effectively with fewer, but higher doses of radiation, a large new international study suggests.

October 2, 2023 — Two liquid biopsy tests that look for the presence of human papillomavirus (HPV) in the blood accurately identified patients with a high risk of cervical cancer recurrence after t

October 1, 2023 — The presence of a clinical navigator to act as a liaison between people with prostate cancer and the healthcare system greatly increases the likelihood that patients, especially Black patients, will receive advanced testing that can help predict

September 29, 2023 — Hologic, Inc., a global leader in women’s health, announced a series of activities promoting the importance of breast cancer screenings throughout Breast Cancer Awareness Month, including a global partnership with Know Your Lemons, a nonprofit organization committed to improving early detection of breast cancer worldwide through creative and

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now